The results of the IL‐6 receptor (IL‐6R) inhibitor tocilizumab on patients with obesity also highlight the importance of this cytokine as a key hotspot in the interaction between obesity and COVID‐19.80 The gene discussed is IL6R; the disease is COVID-19.